Pangaea Oncology (PANG) | Stock Price History & Returns | 2017 - 2025

How has Pangaea Oncology (PANG) stock performed during last 12 months?

Over the last 12 months, Pangaea Oncology has delivered a total return of 17.0%.

• 52-Week High reached EUR1.80 on October 21, 2024.
• 52-Week Low touched EUR1.47 on September 30, 2024.
• Current Price trading at EUR1.72 as of August 10, 2025.

What is Pangaea Oncology's (PANG) total stock return over the past 5 years?

Over the past 5 years, investing EUR10,000.00 in Pangaea Oncology (pang) would have grown to approximately EUR15,926.00 as of August 10, 2025, representing a total return of 59.3%.

This represents a compound annual growth rate (CAGR) of 9.8% over the 5-year period.

How does Pangaea Oncology's Stock 10-year annualized return compare to the Healthcare sector?

Pangaea Oncology (pang) has delivered an annualized return of -3.7% over the past 10 years.

To illustrate: EUR10,000.00 invested in Pangaea Oncology would have grown to EUR6,880.00 over this 10-year period.

This performance should be compared against other companies in the Healthcare sector to understand relative performance.

What was Pangaea Oncology's best-performing year historically?

Pangaea Oncology (pang) has achieved its strongest performance over the 5 years period, delivering a total return of 59.3%.

What is the longest period of consecutive yearly growth Pangaea Oncology has achieved historically?

Pangaea Oncology (pang) shows the following performance across different time periods:

Positive Returns: 12 months (+17.0%), 3 years (+17.8%), 5 years (+59.3%)

Negative Returns: 10 years (-31.2%)

This represents strong consistency in delivering positive returns across different time horizons.

For more common questions about our data, please visit our About Data page.